{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:03:37Z","timestamp":1789956217710,"version":"4.0.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T00:00:00Z","timestamp":1328745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00401-012-0956-x","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T23:14:18Z","timestamp":1328656458000},"page":"747-749","source":"Crossref","is-referenced-by-count":36,"title":["Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington\u2019s, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease"],"prefix":"10.1007","volume":"123","author":[{"given":"Fumiaki","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunikazu","family":"Tanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,9]]},"reference":[{"key":"956_CR1","doi-asserted-by":"crossref","first-page":"16147","DOI":"10.1074\/jbc.M601467200","volume":"281","author":"N Marco De","year":"2006","unstructured":"De Marco N, Buono M, Troise F, Diez-Roux G (2006) Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J Biol Chem 281:16147\u201316156","journal-title":"J Biol Chem"},{"key":"956_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00401-011-0813-3","volume":"121","author":"T Hortobagyi","year":"2011","unstructured":"Hortobagyi T, Troakes C, Nishimura AL et al (2011) Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Acta Neuropathol 121:519\u2013527","journal-title":"Acta Neuropathol"},{"key":"956_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-011-0809-z","volume":"121","author":"H Ito","year":"2011","unstructured":"Ito H, Fujita K, Nakamura M et al (2011) Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol 121:555\u2013557","journal-title":"Acta Neuropathol"},{"key":"956_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature08971","volume":"465","author":"H Maruyama","year":"2010","unstructured":"Maruyama H, Morino H, Ito H et al (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:223\u2013226","journal-title":"Nature"},{"key":"956_CR5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroscience.2011.11.059","volume":"202","author":"S Okita","year":"2012","unstructured":"Okita S, Morigaki R, Koizumi H, Kaji R, Nagahiro S, Goto S (2012) Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington\u2019s disease. Neuroscience 202:363\u2013370","journal-title":"Neuroscience"},{"key":"956_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1440-1789.2011.01199.x","volume":"31","author":"T Osawa","year":"2011","unstructured":"Osawa T, Mizuno Y, Fujita Y, Takatama M, Nakazato Y, Okamoto K (2011) Optineurin in neurodegenerative diseases. Neuropathology 31:569\u2013574","journal-title":"Neuropathology"},{"key":"956_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2011.10.070","volume":"506","author":"C Schwab","year":"2012","unstructured":"Schwab C, Yu S, McGeer EG, McGeer PL (2012) Optineurin in Huntington\u2019s disease intranuclear inclusions. Neurosci Lett 506:149\u2013154","journal-title":"Neurosci Lett"},{"key":"956_CR8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00401-011-0915-y","volume":"123","author":"C Schwab","year":"2012","unstructured":"Schwab C, Yu S, McGeer PL (2012) Optineurin is colocalized with ubiquitin in Marinesco bodies. Acta Neuropathol 123:289\u2013292","journal-title":"Acta Neuropathol"},{"key":"956_CR9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12038-010-0056-9","volume":"35","author":"G Swarup","year":"2010","unstructured":"Swarup G, Nagabhushana A (2010) Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling. J Biosci 35:501\u2013505","journal-title":"J Biosci"},{"key":"956_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jmcb\/mjq005","volume":"2","author":"T Takahashi","year":"2010","unstructured":"Takahashi T, Katada S, Onodera O (2010) Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going? J Mol Cell Biol 2:180\u2013191","journal-title":"J Mol Cell Biol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-0956-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-012-0956-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-0956-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:24:14Z","timestamp":1559049854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-012-0956-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["956"],"URL":"https:\/\/doi.org\/10.1007\/s00401-012-0956-x","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,9]]}}}